HLA Typing For Transplant Market Research, 2033
The global HLA typing for transplant market size was valued at $0.9 billion in 2023, and is projected to reach $1.7 billion by 2033, growing at a CAGR of 6.6% from 2024 to 2033. Major factors driving the market growth are increasing incidences of organ transplantation due to rising chronic diseases and the aging population necessitate precise HLA matching to reduce transplant rejection and improve patient outcomes. Advances in genomic technologies enhance the accuracy and efficiency of HLA typing, further fueling market expansion. Additionally, growing awareness and adoption of personalized medicine are pushing demand for more tailored and effective transplant solutions. Enhanced healthcare infrastructure and supportive government policies also contribute to the market's growth by facilitating broader access to advanced HLA typing techniques.
Market Introduction and Definition
HLA typing, or Human Leukocyte Antigen typing, is a crucial process in organ transplantation that involves identifying the specific genetic markers on the surface of cells, known as HLA molecules. These molecules play a pivotal role in the immune system by presenting peptide fragments to T cells, thereby enabling the body to recognize and respond to foreign substances. In the context of transplantation, accurate HLA typing is essential to match donors and recipients to minimize the risk of transplant rejection.
During the typing process, the HLA genes of both the donor and recipient are analyzed to determine their compatibility. This involves testing for various HLA antigens, including HLA-A, HLA-B, and HLA-DR, among others. A closer match between the donor’s and recipient’s HLA types leads to better transplant outcomes and reduces the likelihood of graft-versus-host disease (GVHD) , where the donor's immune cells attack the recipient's tissues. Advances in molecular techniques, such as PCR-based methods and next-generation sequencing, have significantly improved the precision of HLA typing, allowing for more reliable matching and better overall success rates in transplantation.
Key Takeaways
- The HLA typing for transplant market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major HLA typing for transplant industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
According to HLA typing for transplant market forecast analysis the key factors driving the growth of the market are rising incidence of chronic diseases and organ failures, growing awareness and acceptance of organ transplantation and organ failures and advancements in HLA typing technologies. As the global population ages and the prevalence of chronic conditions such as diabetes, hypertension, and autoimmune disorders increases, the demand for organ transplants has correspondingly grown. These chronic diseases often lead to severe organ damage, necessitating the need for transplants to improve patients' quality of life and survival rates. According to 2024 article by International Society for Heart & Lung Transplantation, more than 4, 600 lung transplants are performed worldwide each year. Thus, the growing prevalence of chronic diseases is expected to significantly contribute in HLA typing for transplant market growth.
Furthermore, organ failures whether due to chronic diseases, genetic factors, or other causes require precise matching between donors and recipients to ensure successful transplant outcomes. HLA typing, which involves identifying human leukocyte antigen markers to match donor organs with recipients, becomes crucial in organ transplantation. Accurate HLA typing minimizes the risk of organ rejection and enhances the effectiveness of the transplant process, making it an essential component of modern transplant medicine.
According to HLA typing for transplant market opportunity analysis growing awareness and acceptance of organ transplantation is a significant driver for the HLA typing for transplant market. As advancements in medical science and surgical techniques continue to evolve, the success rates of organ transplants have improved, leading to increased public recognition and acceptance of these life-saving procedures. This heightened awareness has contributed to a greater understanding of the importance of human leukocyte antigen (HLA) typing in ensuring transplant compatibility. HLA typing is crucial for matching donors and recipients to minimize the risk of rejection and improve transplant outcomes.
Consequently, the rise in organ transplant procedures has driven demand for accurate and reliable HLA typing services. Moreover, as more individuals and healthcare providers become informed about the benefits of precise HLA matching, the market for HLA typing services has expanded, further fueling growth in this sector. This trend reflects a broader shift towards personalized medicine and a commitment to enhancing the efficacy of organ transplantation through advanced diagnostic and matching technologies. Thus, the growing awareness about HLA matching is expected to drive the HLA typing for transplant market size.
Organ Transplantation
The rise in organ transplantation significantly drives the growth of the HLA typing for transplant market. As the number of transplants performed continues to increase, so does the demand for accurate and reliable HLA typing, which is crucial for matching organ donors with recipients to minimize the risk of transplant rejection. In March 2024, the transplantation statistics highlighted the substantial volume of procedures across various organs, including 27, 332 kidney transplants, 10, 660 liver transplants, and smaller yet notable numbers for pancreas, heart, lung, and other organ transplants.
The high frequency of kidney and liver transplants alone underscores the critical need for HLA typing to ensure compatibility and improve patient outcomes. The growing emphasis on personalized medicine and precision in transplantation further fuels the demand for advanced HLA typing technologies, as they play a vital role in enhancing the success rates of organ transplants and optimizing long-term patient health
Market Segmentation
The HLA typing for transplant industry is segmented into technology, product, application, type, end user, and region. By technology, the market is bifurcated into PCR and sequencing. By product, the market is classified into instruments, reagents & consumables, and software & services. By application, the market is divided into diagnostic and research. By type, the market is categorized into organ transplant and tissue. By end user, it is segregated into independent reference laboratories, hospital & transplant center, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America dominated the HLA Typing for Transplant market share in 2023 well-developed healthcare infrastructure that supports complex procedures like organ transplants. This advanced infrastructure includes state-of-the-art laboratories and diagnostic facilities that are essential for HLA typing, ensuring accurate and timely results.
- According to an article by Health Resource and Services Administration, as of March 2024, 4, 545 heart transplantation operations have been performed in the U.S.
- According to a 2024 article by the National Library of Medicine, approximately 17, 000–18, 000 solid organ transplants are performed every year in India.
- According to a 2024 article by Kidney Care UK, there are 40-45, 000 premature deaths in the UK every year due to chronic kidney disease.
- According to a 2023 article by the National Health Service, in UK, organ donation increased by 22% in 2023 as compared to 2022.
Industry Trends
- According to the article by Health Resource and Services Administration, as of March 2024 10, 660 liver transplantation has been performed in U.S.
- According to the 2024 article by American Kidney Fund, about 808, 000 Americans are living with kidney failure.?
- According to the 2024 article by Health Resource and Services Administration, about 17 people die each day waiting for an organ transplant in U.S.
- According to 2024 article by International Society for Heart & Lung Transplantation, more than 5, 000 heart transplants are performed annually worldwide
Competitive Landscape
The major players operating in the HLA typing for transplant market include as Luminex Corporation, Pacific Biosciences of California, Inc, Abbott Laboratories, Bio-Rad Laboratories, BioReference Laboratories, Qiagen N.V., F. Hoffmann-La Roche Ltd, Illumina Inc., Fujirebio, and BAG Diagnostic GmbH. Other players in the HLA Typing for Transplant market are Omixon, Inc., Thermo-Fisher Scientific Inc. CareDx, Inc., and GenDx.
Recent Key Strategies and Developments
- In September 2023, Omixon, Inc. introduced the NanoTYPE RUO Multiplex Human Leukocyte Antigen Amplification kit, which is compatible with the Oxford Nanopore’s MinION Platform. This product aims to enhance the efficiency of HLA typing procedures.
- In November 2022, Illumina, Inc. opened a new Solutions Center in Dubai, aimed at expanding genomics research capabilities in the Middle East.
- In March 2022, Immucor, Inc. launched the MIA FORA NGS Express HLA Typing Software, which is designed to improve the accuracy and speed of HLA typing processes.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hla typing for transplant market analysis from 2024 to 2033 to identify the prevailing hla typing for transplant market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the hla typing for transplant market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global hla typing for transplant market trends, key players, market segments, application areas, and market growth strategies.
HLA Typing for Transplant Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 1.7 Billion |
 Growth Rate | CAGR of 6.6% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Technology |
|
 By Product |
|
 By Application |
|
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Qiagen N.V, Luminex Corporation, Fujirebio, BAG Diagnostic GmbH, Pacific Biosciences of California, Inc, BioReference Laboratories, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Illumina Inc. |
The global HLA typing for transplant market was valued at $0.9 billion in 2023
The market value of HLA Typing for Transplant Market is projected to reach $1.7 billion by 2033
The forecast period for HLA Typing for Transplant Market is 2024-2033.
Major key players that operate in the HLA Typing for Transplant Market are Luminex Corporation, Pacific Biosciences of California, Inc, Abbott Laboratories, Bio-Rad Laboratories, BioReference Laboratories
The base year is 2023 in HLA Typing for Transplant Market
Loading Table Of Content...
